Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) Non Operating Income (2016 - 2025)

Bio-Techne has reported Non Operating Income over the past 17 years, most recently at -$3.7 million for Q4 2025.

  • Quarterly results put Non Operating Income at -$3.7 million for Q4 2025, up 19.06% from a year ago — trailing twelve months through Dec 2025 was -$2.8 million (down 37.34% YoY), and the annual figure for FY2025 was -$3.8 million, up 55.82%.
  • Non Operating Income for Q4 2025 was -$3.7 million at Bio-Techne, down from $333000.0 in the prior quarter.
  • Over the last five years, Non Operating Income for TECH hit a ceiling of $47.4 million in Q3 2022 and a floor of -$58.3 million in Q2 2021.
  • Median Non Operating Income over the past 5 years was -$224500.0 (2023), compared with a mean of -$1.9 million.
  • Biggest five-year swings in Non Operating Income: skyrocketed 542.52% in 2022 and later tumbled 39326.67% in 2024.
  • Bio-Techne's Non Operating Income stood at $23.8 million in 2021, then tumbled by 106.13% to -$1.5 million in 2022, then plummeted by 215.8% to -$4.6 million in 2023, then increased by 1.6% to -$4.5 million in 2024, then grew by 19.06% to -$3.7 million in 2025.
  • The last three reported values for Non Operating Income were -$3.7 million (Q4 2025), $333000.0 (Q3 2025), and $1.0 million (Q2 2025) per Business Quant data.